Digitalis intoxication: a new approach to an old problem
Since the use of the foxglove was first described by Withering almost 200 years ago several digitalis glycosides have been isolated and purified. Of these, two (digoxin and digitoxin) are in common use. They share several properties, including a positive inotropic effect and an action to delay atrioventricular conduction, most of which is mediated by the vagus nerves. In addition, both drugs have a narrow therapeutic indexthat is, the dose that produces toxicity lies close to that which produces clinical benefit. They vary, however, in their chemical structure, a feature that leads to differences in their pharmacokinetics: digoxin is excreted mainly unchanged in the urine, whereas digitoxin undergoes metabolism in the liver, excretion in the bile, and enterohepatic recirculation. Digitalis intoxication may occur whenever the excretory pathways are compromised or an inappropriately large dose of drug is given, or both. Because the glycoside in most common use in Britain is digoxin, the feature that predisposes to intoxication is renal failure, usually consequent on old age.' Occasionally, however, digitalis glycosides are taken in deliberate overdose, and rarely an error in the dose given is made by either medical or nursing staff.
The response to digitalis glycosides varies with many factors, including the type and duration of the heart disease, accompanying anoxia, and the concentrations of sodium, potassium, calcium, and magnesium in the tissues and blood.2 The glycosides inhibit the action of the membrane bound enzyme sodium/potassium ATPase,3 and similar effects occur with hypokalaemia. Hence the latter is an important contributory factor in digitalis intoxication, being particularly likely to occur in patients who are receiving either a benzothiadiazine or a loop type diuretic4 such as frusemide or bumetanide (which also causes magnesium depletion). Hypothyroidism is another predisposing factor for digitalis intoxication, partly because glomerular filtration is depressed.5 In addition, the activity of the sympathetic nervous system may determine whether or not a patient develops a cardiac arrhythmia. Besides diuretics, many other drugs may interact to increase the risks of digitalis intoxication.6 Notable among these are other cardioactive drugs, particularly antiarrhythmic agents.7
Whatever its underlying aetiology, digitalis intoxication is common. Of the various estimates of its prevalence, the highest is from the United States, where almost a third of patients receiving cardiac glycosides when admitted to hospitals in Boston were definitely or possibly intoxicated.8 In Britain, a study from Belfast showed that about a fifth of patients receiving digitalis glycosides developed adverse effects.4 In contrast, of 391 patients attending general practices in Liverpool, only 37 had serum concentrations exceeding the "therapeutic range."9 Nevertheless, intoxication may occur at serum concentrations within the "therapeutic range," especially if the plasma potassium concentration falls below normal.
Most ofthe side effects of digitalis glycosides were recognised by Withering. General symptoms include anorexia, nausea, vomiting, and diarrhoea, but these are non-specific.10 The manifestations in the central nervous system include mistiness or yellowed vision, confusion, and a "psychotic" state in the elderly."1 Cardiac manifestations of toxicity include worsening of heart failure, but almost any disturbance of rhythm and conduction may occur (with the exception of Mobitz type II atrioventricular block, parasystole, and junctional tachycardia).'0 The most frequent abnormalities are ventricular extrasystoles (coupling) and either first or second degree atrioventricular block. Complete atrioventricular dissociation may occur, and atrial tachycardia with atrioventricular block (usually 2:1) is common.
The diagnosis of digitalis toxicity is usually simple. The development of malaise, gastrointestinal upset, or a new arrhythmia in someone who is receiving digitalis glycosides should provoke suspicion. If these features get better after the drug has been withdrawn or its dose reduced then this is further support for the diagnosis. Measurement of the concentration ofthe glycoside in the plasma or serum, however, together with estimation of the plasma potassium concentration may be very helpful. If the latter is normal toxicity is unlikely with plasma digoxin concentrations below 2-5 nmol/l (2 ng/ml), whereas toxicity is very likely with values above 5 nmol/l (4 ng/ml).2 Nevertheless, in patients whose plasma potassium concentrations are below normal plasma glycoside concentrations between 1-3 and 2-5 nmol/l may be associated with toxicity. Assessment of colour vision with the FarnsworthMunsell test may be helpful in confirming the diagnosis in some patients,'3 but in my view pharmacological tests such as the administration of acetylstrophanthidin, edrophonium, or edetic acid are not only unreliable but also potentially dangerous.
The principles of treatment of digitalis toxicity are similar to those underlying the management of all drug overdoses. Firstly, the treatment should be stopped-at least temporarily. Secondly, for digitoxin, absorption from the gastrointestinal tract should be prevented with either cholestyramine or colestipol,"4 both of which will also hasten its elimination from the body. Next, restoration ofthe body stores of potassium is important. If intoxication is mild then correction can be with oral potassium supplements, but if the patient has frequent ventricular ectopic beats more rapid restoration by the intravenous route is preferable, at a rate of 20-40 mmol (mEq) an hour. If the patient has syncopal episodes relating to runs of ventricular ectopic beats an antiarrhythmic will be needed; lignocaine is the safest and most useful since it has little or no depressant effect on conduction through the atrioventricular node. Phenytoin is a worthwhile alternative,'5 perhaps because it opposes the effects of digitalis on membrane bound sodium /potassium ATPase. Alternatively, beta adrenoceptor antagonists such as practolol may revert many disturbances of rhythm induced by digitalis to normal.'6 (These drugs tend to delay conduction in the heart, so a temporary pacing wire should be inserted before they are used lest complete heart block should supervene.) Direct current cardioversion should be reserved for ventricular fibrillation since the treatment is hazardous; very low energy impulses should be tried initially. '7 The most exciting development in the management of digitalis overdosage and intoxication has been the introduction of an antidote-namely, digoxin specific antibodies. These are produced in sheep and isolated by a specific immunoadsorbent method. The whole immunoglobulin has a limited distribution in the body and (although binding digoxin) cannot be excreted by the kidney because of its large molecular weight. Nevertheless, proteolytic digestion with the enzyme papain cleaves the IgG molecule into three fragments: a crystallisable fraction (Fc), which is unwanted, and two Fab fragments, which have a molecular weight of about 50 000 and possess specific antigen binding sites. The results in Smith's series were dramatic: all of the 26 patients showed an initial response and 21 made a full recovery. Of those who died, one did so after recurrence ofthe arrhythmia and was considered to have received inadequate amounts of the antibody. Of the four others, three had had cardiogenic shock for some hours and the fourth sustained anoxic brain damage.
Despite these impressive results, several problems exist. The most important of these is that at present the supply of antibody is very limited. The antibody is derived from sheep serum and might provoke allergic reactions and hence it is recommended that an initial skin sensitivity test should be carried out; after this a small intravenous test dose of the Fab fragments should be given. Nevertheless, in the series reported from Boston no hypersensitivity reactions occurred, and all who have to treat digitalis toxicity will hope that further supplies will be made available for clinical use.
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